COVID-19-related mortality in kidney transplant and dialysis patients: results of the ERACODA collaborationLuuk B. Hilbrands, Elena Zakharova, Michelle J. Pena et al.|Nephrology Dialysis Transplantation|2020Cited by 411
Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double-blind placebo-controlled clinical trialEllen M. Apperloo, Hiddo J.L. Heerspink, José Luis Górriz et al.|Nature Medicine|2024Cited by 95
COVID-19-related mortality in kidney transplant and haemodialysis patients: a comparative, prospective registry-based studyÉric Goffin, Guy Rostoker, Alexandre Candellier et al.|Nephrology Dialysis Transplantation|2021Cited by 83
Effects of Semaglutide on Kidney Parameters in Patients with Obesity and Nondiabetic CKDHiddo Jan L. Heerspink, José Luis Górriz, Ellen M. Apperloo et al.|Journal of the American Society of Nephrology|2024Cited by 0